NIH #5R01CA161001-05
MECHANISMS OF HER2 HETERODIMERIZATION
- Amount
- $315K
- Period
- 2013-03-01 → 2019-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WASHINGTON UNIVERSITY
HER2/EGFR in Cancer Research · Oncology
10 total · 0 active
NIH #5R01CA161001-05
Awarded at WASHINGTON UNIVERSITY
NIH #4R01CA161001-04
Awarded at WASHINGTON UNIVERSITY
NIH #5R01CA161001-02
Awarded at WASHINGTON UNIVERSITY
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
2026-06-12
Interleukin-34–Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis
Cancer Research Communications · 2026-05-21
Clinical Cancer Research · 2026-04-06
Nature Communications · 2026-01-27 · 3 citations